Duration of Antibiotic Therapy for Early (DATE) Ventilator-Associated Pneumonia (VAP) Trial: A Surgical Infection Society Multicenter Randomized Clinical Trial of 4 vs. 7 Days of Definitive Antibiotic Therapy for Early VAP
Duration of Antibiotic Therapy for Early (DATE) Ventilator-Associated Pneumonia (VAP) Trial: A Surgical Infection Society Multicenter Randomized Clinical Trial of 4 vs. 7 Days of Definitive Antibiotic Therapy for Early VAP
The purpose of this study is to see if the amount of antibiotics given for ventilator-associated pneumonia (VAP) can be decreased in order to reduce the risk of adverse effects associated with antibiotics, while at the same time ensuring the participant's safety.
Inclusion Criteria:
Exclusion Criteria:
Age < 18 years
Prior episode of VAP for the index admission
VAP caused by any of the following pathogens:
Causative pathogen not sensitive to choice of initial empiric antibiotic
Antibiotic therapy for > 5 of the last 10 days preceding VAP diagnosis
Septic shock, defined as evidence of tissue hypoperfusion after adequate volume expansion, due to infection, and requiring > 1 vasopressor (17)
Current or recent (within 30 days) use of immunosuppressive medications
LOS > 72 hours at a transferring facility
Pregnancy or lactation
Legal arrest or incarceration
Moribund state in which death is imminent
ECMO (Extracorporeal membrane oxygenation)
Extubation prior to randomization